Since hepatitis D occurs only on the background of hepatitis B
Since hepatitis D occurs only on the background of hepatitis B, vaccination against B simultaneously protects against D. Meanwhile, the incidence of acute hepatitis C remains stable — 0.9 to 1 case per 100,000.
Consensus
- In 2025, Russia reported the lowest incidence of acute hepatitis B in its history, at 0.25 cases per 00,000 population.
- The incidence of acute hepatitis C in Russia has remained stable, at 0.9–1.0 cases per 100,000 population.
- There is a high level of chronic hepatitis cases, with chronic hepatitis C being the most prevalent.
- No vaccine exists for hepatitis C due to the virus's high variability.
- Antiviral drugs can cure hepatitis C in more than 95% of cases.
- Testing for hepatitis C is available to Russians aged 25 and older through the national health program, once every 10 years.
- Rapid LAMP tests for hepatitis B and C were developed and registered in 2025 as part of the federal 'Sanitary Shield' project.
- Hepatitis C often progresses without symptoms, making laboratory testing essential for detection.
- The World Day for the Fight Against Hepatitis is observed on July 28.
Points of divergence
- The professor stated that the incidence of hepatitis C in Russia is approximately 39 cases per 100,000, which contradicts the consistent figure of 0.9–1.0 per 100,000 reported by other sources. — vesti
- The professor claimed that new direct-acting drugs have a cure rate of up to 98%, while other sources report over 95%. — vesti
- The main symptom of hepatitis is jaundice, with specific signs including yellowing of the eyes or skin, dark urine, and pale stool, which is not mentioned in other sources. — m24
- The protection against hepatitis D is provided by the hepatitis B vaccine, which is not mentioned in other sources. — riamo
Coverage (4 sources)
- Record-low incidence of acute hepatitis B recorded in Russia — РИАМО
- Test for antibodies to hepatitis C became available to Russians from 25 years old via OMS — Москва 24
- Over 27 million people in Russia underwent hepatitis C testing in 2025 — Интерфакс
- Scientist: Russia has developed drugs with up to 98% efficacy against Hepatitis C — Вести
Key entities
- Russia
- Moscow
- Rospotrebnadzor
- INTERFAX.RU
- TASS
- Yevgeny Samarin
- RIA Novosti
- IT 'News'
- Ministry of Health
- RAS
- OMS Photo
- Central Scientific Research Institute of Epidemiology
- Mikhail Mikhailov
- Vladimir Chulanov
More on Yevgeny Samarin
- 60K register for Moscow Marathon
- Heating in residential buildings and social facilities was proposed…
- Zelensky says he'll visit Moscow 'on a rocket'